Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Sale | 2024-04-03 4:02 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 240 | $419 | $100,560 | 7,500 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 4:29 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 883 | $425.7 | $375,893 | 7,965 (Direct) | View |
| 2024-02-12 Sale | 2024-02-13 4:48 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 1,374 | $420.24 | $577,410 | 9,676 (Direct) | View |
| 2023-05-30 Sale | 2023-06-01 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 289 | $329.82 | $95,318 | 6,838 (Direct) | View |
| 2023-02-27 Sale | 2023-02-28 4:44 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 1,207 | $287.55 | $347,072 | 7,303 (Direct) | View |
| 2022-04-25 Sale | 2022-04-27 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 327 | $269.55 | $88,143 | 3,496 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Tax Withholding | 2024-04-03 4:02 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 225 | $418.1 | 7,500 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 4:29 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 828 | $431.79 | 7,965 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 591 | $422.74 | 9,676 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-08 4:20 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 4,803 | $0 | 11,641 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 176 | $313.74 | 7,127 (Direct) | View |
| 2023-02-24 Tax Withholding | 2023-02-28 4:44 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 502 | $289.12 | 7,303 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:32 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 5,516 | $0 | 9,012 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-05 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 137 | $263.09 | 3,823 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 2,566 | $0 | 3,960 (Direct) | View |
Ownership | 2021-05-03 5:05 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 0 | $0 | 1,394 (Direct) | View |